Suppr超能文献

胎龄及产前和围产期事件对早产儿凝血状态的影响。

Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants.

作者信息

Salonvaara M, Riikonen P, Kekomäki R, Vahtera E, Mahlamäki E, Halonen P, Heinonen K

机构信息

Department of Pediatrics, Kuopio University Hospital and Kuopio University, Kuopio, Finland.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2003 Jul;88(4):F319-23. doi: 10.1136/fn.88.4.f319.

Abstract

OBJECTIVE

To study prospectively the effects of prematurity and perinatal events on the coagulation status of premature infants.

PATIENTS AND MAIN OUTCOME MEASURES

Blood samples from premature infants born before 37 gestational weeks were taken for analysis of coagulation factors II, V, VII, and X and platelet count.

RESULTS

A total of 125 premature infants, 71 boys, were studied at the median postnatal age of 40 minutes (range 12-100). The lowest median activities of coagulation factors II, V, VII, and X and the platelet count were observed, as expected, in infants (n = 21) born at 24-27 weeks gestation. Twin B (n = 14) had lower median activities of coagulation factors II, V, VII, and X than twin A. Infants with evidence of mild asphyxia (Apgar score at 5 minutes < 7 or cord pH < 7.26) had significantly (p < 0.05) lower levels of coagulation factors II, V, VII, and X and platelet counts than infants without asphyxia. Infants who were small for gestational age (SGA) had significantly (p < 0.05) lower levels of coagulation factors V and VII and platelet counts than infants of appropriate size for gestational age. Other prenatal and perinatal variables examined (sex, maternal hypertension and/or pre-eclampsia, antenatal steroid use, mode of delivery, Apgar scores) did not show any significant associations with coagulation status, which may be explained by the small number of infants studied.

CONCLUSIONS

The data strongly suggest that there are distinct differences in specific coagulation tests in different patient populations, which could assist in the identification of extremely preterm, SGA, or asphyxiated preterm infants who may be susceptible to haemorrhagic problems perinatally.

摘要

目的

前瞻性研究早产和围产期事件对早产儿凝血状态的影响。

患者及主要观察指标

采集孕37周前出生的早产儿血样,分析凝血因子II、V、VII和X以及血小板计数。

结果

共研究了125例早产儿,其中71例为男婴,出生后中位年龄为40分钟(范围12 - 100分钟)。正如预期的那样,在孕24 - 27周出生的婴儿(n = 21)中观察到凝血因子II、V、VII和X的中位活性以及血小板计数最低。双胞胎B(n = 14)的凝血因子II、V、VII和X的中位活性低于双胞胎A。有轻度窒息证据(5分钟时阿氏评分<7或脐血pH<7.26)的婴儿,其凝血因子II、V、VII和X水平以及血小板计数显著低于(p<0.05)无窒息的婴儿。小于胎龄儿(SGA)的凝血因子V和VII水平以及血小板计数显著低于(p<0.05)适于胎龄儿。所检查的其他产前和围产期变量(性别、母亲高血压和/或先兆子痫、产前使用类固醇、分娩方式、阿氏评分)与凝血状态均无显著关联,这可能是由于研究的婴儿数量较少所致。

结论

数据有力地表明,不同患者群体在特定凝血检测方面存在明显差异,这有助于识别可能在围产期易发生出血问题的极早产儿、小于胎龄儿或窒息早产儿。

相似文献

引用本文的文献

6
Developmental hemostasis in the neonatal period.新生儿期的发育性止血。
World J Pediatr. 2022 Jan;18(1):7-15. doi: 10.1007/s12519-021-00492-3. Epub 2022 Jan 4.
7
Neonatal coagulopathies: A review of established and emerging treatments.新生儿凝血障碍:已确立和新兴治疗方法的综述。
Exp Biol Med (Maywood). 2021 Jun;246(12):1447-1457. doi: 10.1177/15353702211006046. Epub 2021 Apr 15.

本文引用的文献

1
COAGULATION STUDIES WITH FETAL BLOOD.
Biol Neonat. 1964;7:319-27. doi: 10.1159/000239936.
4
Coagulation and fibrinolytic systems in the ill preterm newborn.患病早产儿的凝血和纤维蛋白溶解系统。
Acta Paediatr. 1997 Oct;86(10):1100-4. doi: 10.1111/j.1651-2227.1997.tb14816.x.
6
Neonatal thrombocytopenia.新生儿血小板减少症
Clin Perinatol. 1984 Jun;11(2):359-91.
7
Coagulation studies in severe birth asphyxia.重度新生儿窒息的凝血研究。
Arch Dis Child. 1971 Jun;46(247):253-6. doi: 10.1136/adc.46.247.253.
8
The development of hemostasis in the human fetus and newborn infant.
J Pediatr. 1971 Nov;79(5):838-53. doi: 10.1016/s0022-3476(71)80405-5.
10
Newborn haemostasis.新生儿止血
Clin Haematol. 1985 Jun;14(2):443-60.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验